Confirma releases CADstream study results at RSNA show

Computer-aided detection (CAD) firm Confirma of Kirkland, WA, announced the results of a recent study on its CADstream system for breast MRI at the 2006 RSNA meeting in Chicago.

The study, by researchers at the University of California, San Francisco, found that CADstream's breast MR tumor-volume measurements can predict the length of recurrence-free survival in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.

The findings also support the use of volumetric measurements of tumor response as an end point for survival outcomes, Confirma said.

By AuntMinnie.com staff writers
December 1, 2006

Related Reading

Road to RSNA, Confirma, November 9, 2006

Road to RSNA, Confirma, November 9, 2006

Confirma teams with Medipattern, May 25, 2006

Confirma CAD available through Berlex program, May 22, 2006

Confirma bolsters CADstream, May 8, 2006

Copyright © 2006 AuntMinnie.com

Page 1 of 569
Next Page